Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Breast Neoplasms
×
Risedronic Acid
×
Clear all
Filters
3
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled